Skip to main content
. Author manuscript; available in PMC: 2016 Sep 22.
Published in final edited form as: Int J Hematol. 2015 Mar 27;101(5):428–437. doi: 10.1007/s12185-015-1781-5

Table 1.

Factors altering microbiota homeostasis during allo-HSCT and proposed therapies targeting restoration in intestinal microbial diversity

Dysbiosis (→ Inflammation/epithelial
damage)
Eubiosis (→ Immune regulation/epithelial restoration)
GVHD Growth factors (KGF)
Conditioning chemotherapy/irradiation Probiotics (Lactobacillus)
Antimicrobial therapy Cellular therapy (ISC, MSC)
Alloreactivity Cytokines (IL-22)
Supplemental nutrition (intralipids) SCFA (butyrate/acetate)
Mucositis Polysaccharide A/vitamin A
Infection (viral/bacterial) Antimicrobial peptides (REGIIIα)
Reduced intensity conditioning
Narrow-spectrum antimicrobials